RSV in transplant and immunocompromised patients
Respiratory syncytial virus (RSV) is a significant cause of morbidity and mortality in infants, older adults, and patients with weakened immune systems. Disease severity differs by underlying immunologic pathologies, with worse outcomes associated with progression from upper to lower respiratory dis...
Gespeichert in:
| Veröffentlicht in: | Cleveland Clinic journal of medicine 2024-09, Vol.91 (9 suppl 1), p.S34-S41 |
|---|---|
| Hauptverfasser: | , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | S41 |
|---|---|
| container_issue | 9 suppl 1 |
| container_start_page | S34 |
| container_title | Cleveland Clinic journal of medicine |
| container_volume | 91 |
| creator | Koval, Christine E Gonzalez, Blanca E |
| description | Respiratory syncytial virus (RSV) is a significant cause of morbidity and mortality in infants, older adults, and patients with weakened immune systems. Disease severity differs by underlying immunologic pathologies, with worse outcomes associated with progression from upper to lower respiratory disease. In this review we address the impact of RSV in immunocompromised populations, and discuss the limited available treatments and the potential impact of newer RSV prevention strategies on immunocompromised adults and children. |
| doi_str_mv | 10.3949/ccjm.91.s1.06 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3100913495</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3100913495</sourcerecordid><originalsourceid>FETCH-LOGICAL-c179t-30ace689c167a59386bc9bfbbccc9c352e2ba924c2e0d37b98164a4a7e3244e63</originalsourceid><addsrcrecordid>eNo9kEtLxDAURoMoTh1dupUu3bTem6Rp71IGXzAg-NqGJM1Ah0lbm3bhv7fDjK6-zeFw-Bi7RsgFSbpzbhtywjxiDuqEJUiCMl4pOmUJVIQZYgELdhHjFoAXyOmcLQRxgQogYfD2_pU2bToOpo39zrRjato6bUKY2s51oR-60ERfp70ZG9-O8ZKdbcwu-qvjLtnn48PH6jlbvz69rO7XmcOSxkyAcV5V5FCVpiBRKevIbqx1zpETBffcGuLScQ-1KC1VqKSRpvSCS-mVWLLbg3cu-J58HPXc4fxuTvTdFLVAAEIhqZjR7IC6oYtx8BvdD00ww49G0PuT9P4kTagjatirb47qyQZf_9N_r4hf8epjGA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3100913495</pqid></control><display><type>article</type><title>RSV in transplant and immunocompromised patients</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Koval, Christine E ; Gonzalez, Blanca E</creator><creatorcontrib>Koval, Christine E ; Gonzalez, Blanca E</creatorcontrib><description>Respiratory syncytial virus (RSV) is a significant cause of morbidity and mortality in infants, older adults, and patients with weakened immune systems. Disease severity differs by underlying immunologic pathologies, with worse outcomes associated with progression from upper to lower respiratory disease. In this review we address the impact of RSV in immunocompromised populations, and discuss the limited available treatments and the potential impact of newer RSV prevention strategies on immunocompromised adults and children.</description><identifier>ISSN: 0891-1150</identifier><identifier>ISSN: 1939-2869</identifier><identifier>EISSN: 1939-2869</identifier><identifier>DOI: 10.3949/ccjm.91.s1.06</identifier><identifier>PMID: 39231600</identifier><language>eng</language><publisher>United States</publisher><subject>Adult ; Antiviral Agents - therapeutic use ; Child ; Humans ; Immunocompromised Host ; Infant ; Respiratory Syncytial Virus Infections - immunology ; Respiratory Syncytial Virus Infections - prevention & control</subject><ispartof>Cleveland Clinic journal of medicine, 2024-09, Vol.91 (9 suppl 1), p.S34-S41</ispartof><rights>Copyright © 2024 The Cleveland Clinic Foundation. All Rights Reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27922,27923</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39231600$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Koval, Christine E</creatorcontrib><creatorcontrib>Gonzalez, Blanca E</creatorcontrib><title>RSV in transplant and immunocompromised patients</title><title>Cleveland Clinic journal of medicine</title><addtitle>Cleve Clin J Med</addtitle><description>Respiratory syncytial virus (RSV) is a significant cause of morbidity and mortality in infants, older adults, and patients with weakened immune systems. Disease severity differs by underlying immunologic pathologies, with worse outcomes associated with progression from upper to lower respiratory disease. In this review we address the impact of RSV in immunocompromised populations, and discuss the limited available treatments and the potential impact of newer RSV prevention strategies on immunocompromised adults and children.</description><subject>Adult</subject><subject>Antiviral Agents - therapeutic use</subject><subject>Child</subject><subject>Humans</subject><subject>Immunocompromised Host</subject><subject>Infant</subject><subject>Respiratory Syncytial Virus Infections - immunology</subject><subject>Respiratory Syncytial Virus Infections - prevention & control</subject><issn>0891-1150</issn><issn>1939-2869</issn><issn>1939-2869</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kEtLxDAURoMoTh1dupUu3bTem6Rp71IGXzAg-NqGJM1Ah0lbm3bhv7fDjK6-zeFw-Bi7RsgFSbpzbhtywjxiDuqEJUiCMl4pOmUJVIQZYgELdhHjFoAXyOmcLQRxgQogYfD2_pU2bToOpo39zrRjato6bUKY2s51oR-60ERfp70ZG9-O8ZKdbcwu-qvjLtnn48PH6jlbvz69rO7XmcOSxkyAcV5V5FCVpiBRKevIbqx1zpETBffcGuLScQ-1KC1VqKSRpvSCS-mVWLLbg3cu-J58HPXc4fxuTvTdFLVAAEIhqZjR7IC6oYtx8BvdD00ww49G0PuT9P4kTagjatirb47qyQZf_9N_r4hf8epjGA</recordid><startdate>20240904</startdate><enddate>20240904</enddate><creator>Koval, Christine E</creator><creator>Gonzalez, Blanca E</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20240904</creationdate><title>RSV in transplant and immunocompromised patients</title><author>Koval, Christine E ; Gonzalez, Blanca E</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c179t-30ace689c167a59386bc9bfbbccc9c352e2ba924c2e0d37b98164a4a7e3244e63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Adult</topic><topic>Antiviral Agents - therapeutic use</topic><topic>Child</topic><topic>Humans</topic><topic>Immunocompromised Host</topic><topic>Infant</topic><topic>Respiratory Syncytial Virus Infections - immunology</topic><topic>Respiratory Syncytial Virus Infections - prevention & control</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Koval, Christine E</creatorcontrib><creatorcontrib>Gonzalez, Blanca E</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Cleveland Clinic journal of medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Koval, Christine E</au><au>Gonzalez, Blanca E</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>RSV in transplant and immunocompromised patients</atitle><jtitle>Cleveland Clinic journal of medicine</jtitle><addtitle>Cleve Clin J Med</addtitle><date>2024-09-04</date><risdate>2024</risdate><volume>91</volume><issue>9 suppl 1</issue><spage>S34</spage><epage>S41</epage><pages>S34-S41</pages><issn>0891-1150</issn><issn>1939-2869</issn><eissn>1939-2869</eissn><abstract>Respiratory syncytial virus (RSV) is a significant cause of morbidity and mortality in infants, older adults, and patients with weakened immune systems. Disease severity differs by underlying immunologic pathologies, with worse outcomes associated with progression from upper to lower respiratory disease. In this review we address the impact of RSV in immunocompromised populations, and discuss the limited available treatments and the potential impact of newer RSV prevention strategies on immunocompromised adults and children.</abstract><cop>United States</cop><pmid>39231600</pmid><doi>10.3949/ccjm.91.s1.06</doi><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0891-1150 |
| ispartof | Cleveland Clinic journal of medicine, 2024-09, Vol.91 (9 suppl 1), p.S34-S41 |
| issn | 0891-1150 1939-2869 1939-2869 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_3100913495 |
| source | MEDLINE; EZB-FREE-00999 freely available EZB journals |
| subjects | Adult Antiviral Agents - therapeutic use Child Humans Immunocompromised Host Infant Respiratory Syncytial Virus Infections - immunology Respiratory Syncytial Virus Infections - prevention & control |
| title | RSV in transplant and immunocompromised patients |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-13T11%3A33%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=RSV%20in%20transplant%20and%20immunocompromised%20patients&rft.jtitle=Cleveland%20Clinic%20journal%20of%20medicine&rft.au=Koval,%20Christine%20E&rft.date=2024-09-04&rft.volume=91&rft.issue=9%20suppl%201&rft.spage=S34&rft.epage=S41&rft.pages=S34-S41&rft.issn=0891-1150&rft.eissn=1939-2869&rft_id=info:doi/10.3949/ccjm.91.s1.06&rft_dat=%3Cproquest_cross%3E3100913495%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3100913495&rft_id=info:pmid/39231600&rfr_iscdi=true |